NO178306C - Analogifremgangsmåte ved fremstilling av bombesin-antagonistpeptid - Google Patents

Analogifremgangsmåte ved fremstilling av bombesin-antagonistpeptid

Info

Publication number
NO178306C
NO178306C NO892060A NO892060A NO178306C NO 178306 C NO178306 C NO 178306C NO 892060 A NO892060 A NO 892060A NO 892060 A NO892060 A NO 892060A NO 178306 C NO178306 C NO 178306C
Authority
NO
Norway
Prior art keywords
naturally occurring
bombesin
peptide
analog
peptide bond
Prior art date
Application number
NO892060A
Other languages
English (en)
Other versions
NO892060L (no
NO892060D0 (no
NO178306B (no
Inventor
David H Coy
Jacques-Pierre Moreau
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of NO892060D0 publication Critical patent/NO892060D0/no
Publication of NO892060L publication Critical patent/NO892060L/no
Publication of NO178306B publication Critical patent/NO178306B/no
Publication of NO178306C publication Critical patent/NO178306C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086Bombesin; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO892060A 1987-09-24 1989-05-23 Analogifremgangsmåte ved fremstilling av bombesin-antagonistpeptid NO178306C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10057187A 1987-09-24 1987-09-24
PCT/US1988/003286 WO1989002897A1 (en) 1987-09-24 1988-09-23 Therapeutic peptides

Publications (4)

Publication Number Publication Date
NO892060D0 NO892060D0 (no) 1989-05-23
NO892060L NO892060L (no) 1989-07-21
NO178306B NO178306B (no) 1995-11-20
NO178306C true NO178306C (no) 1996-02-28

Family

ID=22280431

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892060A NO178306C (no) 1987-09-24 1989-05-23 Analogifremgangsmåte ved fremstilling av bombesin-antagonistpeptid

Country Status (9)

Country Link
EP (1) EP0309297B1 (no)
JP (1) JP2795449B2 (no)
AT (1) ATE113961T1 (no)
DE (1) DE3852086T2 (no)
DK (1) DK249489A (no)
ES (1) ES2065336T3 (no)
FI (1) FI100719B (no)
NO (1) NO178306C (no)
WO (1) WO1989002897A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084555A (en) * 1989-08-21 1992-01-28 The Administrators Of The Tulane Educational Fund An octapeptide bombesin analog
US5877277A (en) 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
GB8808768D0 (en) * 1988-04-14 1988-05-18 Erba Carlo Spa Peptide ligands for bombesin receptors
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds
GB2231051B (en) * 1989-05-05 1992-12-16 Erba Carlo Spa Bombesin antagonists
HUT58763A (en) * 1989-11-06 1992-03-30 Erba Carlo Spa Process for producing reduced irreverzible bombezin antagonists and pharmaceutical compositions containing them as active components
CA2030212A1 (en) * 1989-11-22 1991-05-23 Judson V. Edwards Peptides
US5834433A (en) * 1990-07-26 1998-11-10 Merrell Pharmaceuticals Inc. Compounds and pharmaceutical uses of peptides of bombesin and GRP
ZA915740B (en) * 1990-07-26 1992-05-27 Merrell Dow Pharma Peptides
US5244883A (en) * 1990-11-29 1993-09-14 The Administrators Of The Tulane Educational Fund Nonapeptide bombesin antagonists
US5369094A (en) * 1990-11-29 1994-11-29 The Administrators Of The Tulane Educational Fund Polypeptide bombesin antagonists
DE69221486T2 (de) * 1991-05-23 1998-03-19 Merrell Pharma Inc Bombesinanaloge
JPH07505865A (ja) * 1992-02-07 1995-06-29 メレルダウファーマスーティカルズ インコーポレイテッド ボンベシンのフェニルアラニン類似体類
US6492330B1 (en) 1996-08-16 2002-12-10 National Institute Of Immunology Antiangiogenic drugs
US6156725A (en) * 1996-08-16 2000-12-05 National Institute Of Immunology Drug for the treatment of cancer
EP0835662B1 (en) * 1996-10-08 2001-11-14 National Institute of Immunology A drug for the treatment of cancer
IL145406A0 (en) 1999-03-29 2002-06-30 Procter & Gamble Melanocortin receptor ligands
US6316414B1 (en) 2000-07-31 2001-11-13 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
US8420050B2 (en) 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7611692B2 (en) 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7226577B2 (en) 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
US7922998B2 (en) 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7850947B2 (en) 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
CA2523197C (en) 2003-04-22 2016-05-24 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Peptide vectors
CA2617294A1 (en) * 2005-08-03 2007-02-08 Boehringer Ingelheim International Gmbh Substituted ethane-1,2-diamines for the treatment of alzheimer's disease ii
US8557776B2 (en) * 2006-09-08 2013-10-15 Bayer Pharma AG Compounds and methods for 18F labeled agents
US20110171191A1 (en) 2008-06-12 2011-07-14 Syntaxin Limited Suppression of neuroendocrine diseases
AU2009259034B2 (en) 2008-06-12 2013-10-31 Ipsen Bioinnovation Limited Suppression of cancers
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
EP2198878A1 (en) 2008-12-18 2010-06-23 University Of Miami Polypeptide bombesin antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207311A (en) 1977-07-18 1980-06-10 The Salk Institute For Biological Studies Peptides having analgesic and thermoregulative properties

Also Published As

Publication number Publication date
DK249489D0 (da) 1989-05-23
DE3852086D1 (de) 1994-12-15
DK249489A (da) 1989-07-20
EP0309297A3 (en) 1990-07-04
ATE113961T1 (de) 1994-11-15
WO1989002897A1 (en) 1989-04-06
AU2710288A (en) 1989-04-18
NO892060L (no) 1989-07-21
ES2065336T3 (es) 1995-02-16
AU622123B2 (en) 1992-04-02
EP0309297A2 (en) 1989-03-29
NO892060D0 (no) 1989-05-23
FI892507A0 (fi) 1989-05-23
JPH02502016A (ja) 1990-07-05
NO178306B (no) 1995-11-20
EP0309297B1 (en) 1994-11-09
JP2795449B2 (ja) 1998-09-10
DE3852086T2 (de) 1995-05-18
FI892507A (fi) 1989-05-23
FI100719B (fi) 1998-02-13

Similar Documents

Publication Publication Date Title
NO178306C (no) Analogifremgangsmåte ved fremstilling av bombesin-antagonistpeptid
KR900701827A (ko) 치료용 펩타이드
FI920737A0 (fi) Terapeutiska peptider.
LV10108A (lv) Sunu proliferacijas inhibitori farmaceitiska kompozicija savienojumu iegusanas metode sunu proliferacijas inhibesanas panemieni
DK0438566T3 (da) Substans P-antagonister
ES2084635T3 (es) Derivados peptidicos utiles como antagonistas de la bombesina y del peptido que libera la gastrina.
ATE107315T1 (de) Menschlicher plazentarer angiogenischer faktor, geeignet für die reizung der kapillarsynthese, der endothelzellprotease, der dns-synthese und der absiedlung.
WO1999001567A3 (en) Methods and compositions for a deubiquitinating enzyme and variants thereof
PT93320A (pt) Processo para a preparacao de peptideos terapeuticos